Y
Hacker News
new
|
ask
|
show
|
jobs
by
FeteCommuniste
21 days ago
Yes. Potentially life-saving drugs in RCTs are usually compared to "standard of care," i.e. already-approved treatments, not to placebos.
1 comments
qsera
21 days ago
So if both the standard of care as well as the drug being trials have the same side effects, would they be included in the package insert/drug literature? Because the incidence rate of it would be same for both the groups?
link